Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 1, 2013, Pages 67-77

  Blank, Fabian ^a   Stumbles, Philip A ^b,c   Seydoux, Emilie ^a   Holt, Patrick G ^b   Fink, Alke ^d   Rothen Rutishauser, Barbara ^d   Strickland, Deborah H ^b   Von Garnier, Christophe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

^d UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Alveolar macrophages; Dendritic cells; Nanoparticles; Trafficking; Uptake

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; POLYSTYRENE;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SUBPOPULATION; CONFOCAL MICROSCOPY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; LUNG PARENCHYMA; LYMPH NODE; MOUSE; NONHUMAN; PARTICLE SIZE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; LUNG; LYMPH NODES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; OVALBUMIN; PARTICLE SIZE; POLYSTYRENES; TIME FACTORS;

EID: 84883137539     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0387OC     Document Type: Article

References (46)

1. Zrazhevskiy P, Sena M, Gao XH. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev 2010; 39:4326-4354.
2. Nembrini C, Stano A, Dane KY, Ballester M, van der Vlies AJ, Marsland BJ, Swartz MA, Hubbell JA. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci USA 2011;108:E989-E997.
3. Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005;298:315-322.
4. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging 2010;9:291-310.
5. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Minireview: nanoparticles and the immune system. Endocrinology 2010;151:458-465.
6. Patton JS. Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 1996;19:3-36.
7. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug 2002;19:425-498.
8. Blank F, Stumbles P, von Garnier C. Opportunities and challenges of the pulmonary route for vaccination. Expert Opin Drug Deliv 2011;8:547-563.
9. Kuehl PJ, Anderson TL, Candelaria G, Gershman B, Harlin K, Hesterman JY, Holmes T, Hoppin J, Lackas C, Norenberg JP, et al. Regional particle size dependent deposition of inhaled aerosols in rats and mice. Inhal Toxicol 2012;24:27-35.
10. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002;65:1513-1530.
11. Brand P, Haussinger K, MeyerT, ScheuchG, Schulz H, Selzer T, Heyder J. Intrapulmonary distribution of deposited particles. J Aerosol Med 1999; 12:275-284.
12. Tsuda A, Rogers RA, Hydon PE, Butler JP. Chaotic mixing deep in the lung. Proc Natl Acad Sci USA 2002;99:10173-10178.
13. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001;74:1-8.
14. Philipson K, Falk R, Svartengren M, Jarvis N, Bailey M, Bergmann R, Hofmann W, Camner P. Does lung retention of inhaled particles depend on their geometric diameter? Exp Lung Res 2000;26:437-455.
15. Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Haussinger K, Kreyling WG. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 2008;177:426-432.
16. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 2010;28:1300-1303.
17. Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA 2002;99:12001-12005.
18. McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, Stumbles PA, Wells TNC, Holt PG. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996;184:2429-2432.
19. Holt PG. Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc Am Thorac Soc 2005;2:116-120.
20. von Garnier C, Filgueira L,WikstromM, Smith M, Thomas JA, Strickland DH, Holt PG, Stumbles PA. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J Immunol 2005;175:1609-1618.
21. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009;15:410-416.
22. Beaty SR, Rose CE, Sung SSJ. Diverse and potent chemokine production by lung CD11b(high) dendritic cells in homeostasis and in allergic lung inflammation. J Immunol 2007;178:1882-1895.
23. Sung SSJ, Fu SM, Rose CE, Gaskin F, Ju ST, Beaty SR. A major lung CD103 (alpha(E))-beta(7) integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006;176:2161-2172.
24. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, MeradM, Randolph GJ. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J ExpMed 2008;205:2839-2850.
25. Ballesteros-Tato A, Leon B, Lund FE, Randall TD. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(1) T cell responses to influenza. Nat Immunol 2010;11: 216-224.
26. Desch AN, Randolph GJ,Murphy K, Gautier EL, Kedl RM, LahoudMH, Caminschi I, Shortman K, Henson PM, Jakubzick CV. CD103(1) pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med 2011;208:1789-1797.
27. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008;38:1404-1413.
28. Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ.Modulation of dendritic cell trafficking to and from the airways. J Immunol 2006; 176:3578-3584.
29. Sarlo K, Blackburn KL, Clark ED, Grothaus J, Chaney J, Neu S, Flood J, Abbott D, Bohne C, Casey K, et al. Tissue distribution of 20 nm, 100 nm and 1000 nm fluorescent polystyrene latex nanospheres following acute systemic or acute and repeat airway exposure in the rat. Toxicology 2009;263:117-126.
30. von Garnier C, Wikstrom ME, Zosky G, Turner DJ, Sly PD, Smith M, Thomas JA, Judd SR, Strickland DH, Holt PG, et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol 2007;179:5748-5759.
31. Wikstrom ME, Batanero E, Smith M, Thomas JA, von Garnier C, Holt PG, Stumbles PA. Influence of mucosal adjuvants on antigen passage and CD41 T cell activation during the primary response to airborne allergen. J Immunol 2006;177:913-924.
32. Blank F, Gerber P, Rothen-Rutishauser B, Sakulkhu U, Salaklang J, De Peyer K, Gehr P, Nicod LP, Hofmann H, Geiser T, et al. Biomedical nanoparticles modulate specific CD41 T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011;5:606-621.
33. Lyons AB, Parish CR. Determination of lymphocyte division by flowcytometry. J Immunol Methods 1994;171:131-137.
34. Roederer M. Interpretation of cellular proliferation data: avoid the panglossian. Cytometry A 2011;79A:95-101.
35. Fear VS, Burchell JT, Lai SP, WikstromME, Blank F, von Garnier C, Turner DJ, Sly PD, Holt PG, Strickland DS, et al. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4(1) T cell proliferation during the induction of inhalation tolerance. J Immunol 2011;187:4561-4570.
36. Strickland DH, Thomas JA, Mok D, Blank F, McKenna KL, Larcombe AN, Sly PD, Holt PG. Defective aeroallergen surveillance by airway mucosal dendritic cells as a determinant of risk for persistent airways hyper-responsiveness in experimental asthma. Mucosal Immunol 2012;5:332-341.
37. Langenback EG, Bergofsky EH, Halpern JG, Foster WM. Supramicronsized particle clearance from alveoli: route and kinetics. J Appl Physiol 1990;69:1302-1308.
38. Thornton EE, Looney MR, Bose O, Sen D, Sheppard D, Locksley R, Huang XZ, KrummelMF. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J Exp Med 2012;209:1183-1199.
39. Jahnsen FL, Strickland DH, Thomas JA, Tobagus IT, Napoli S, Zosky GR, Turner DJ, Sly PD, Stumbles PA, Holt PG. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol 2006;177:5861-5867.
40. Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 2007;36:669-677.
41. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, Shortman K, Carbone FR, HeathWR. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 2004; 101:8670-8675.
42. Takenaka S, Moller W, Semmler-Behnke M, Karg E, Wenk A, Schmid O, Stoeger T, Jennen L, Aichler M, Walch A, et al. Efficient internalization and intracellular translocation of inhaled gold nanoparticles in rat alveolar macrophages. Nanomedicine 2012;7: 855-865.
43. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 2001;193:51-60.
44. Jakubzick C, Helft J, Kaplan TJ, Randolph GJ. Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen. J Immunol Methods 2008;337:121-131.
45. Hardy CL, LeMasurier JS, Belz GT, Scalzo-Inguanti K, Yao J, Xiang SD, Kanellakis P, Bobik A, Strickland DH, Rolland JM, et al. Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol 2012; 188:1431-1441.
46. Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IFC, Plebanski M. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol 2004;173:3148-3154.